Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer - Burgermeister, Elke; Höde, Patrick; Betge, Johannes; Gutting, Tobias; Merkel, Andreas; Nowak, Daniel; Rückert, Felix; Sticht, Carsten; Breitkopf-Heinlein, Katja; Schulte, Nadine; Härtel, Nicolai; Belle, Sebastian; et al. (OncoTarget, 2017)
Gesehen am 30.08.2018